Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • colinmolter
    Member
    • Jul 2011
    • 11

    #1

    cuffdiff2 fails to find diff expressed genes!!??

    Hello,

    I processed 8 breast cancer samples, 4ER+ and 4ER- using tophat2/cufflinks2/cuffmerge2/cuffdiff2/cummeRbund.

    The expression of the gene GREB1 is nearly equal to 0 for the 4 ER-
    and ~100 for ER+:

    cuff <- readCufflinks()
    expr=repFpkmMatrix(genes(cuff))
    expr[rownames(expr)=='XLOC_011466',]
    Neg_0 Neg_1 Neg_2 Neg_3 Pos_0 Pos_1 Pos_2 Pos_3
    XLOC_011466 0.182529 0.791468 0.721075 0.15861 35.9609 231.247 64.1414 39.4893

    However, the result of cuffdiff is:
    diffData(getGene(cuff, 'GREB1'))
    gene_id sample_1 sample_2 status value_1 value_2
    log2_fold_change test_stat p_value q_value significant
    1 XLOC_011466 Neg Pos OK 0.460534 92.726
    7.65352 -1.1267 0.25987 0.999954 no

    How can you explain this. It seems not consistent for me. I would have
    expected a nice q value, a significant test, etc.

    thanks for feedbacks,
    colin

    ps. data were downloaded from SRA/GEO : GSE27003 and are available at inSilico: https://insilico.ulb.ac.be/app/browse?q=GSE27003

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...